Skip to content

Clinical trials

Completed Phase 2/3 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2/3 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20062
20072
20094
20102
20112
20122
20131
20143
20151
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis2
Patrick Murphy2
Aeris Therapeutics1
AstraZeneca1
Barts & The London NHS Trust1
Bastiaan Driehuys1
BeerYaakov Mental Health Center1
Broncus Technologies1
CEU San Pablo University1
Danish Procalcitonin Study Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive25
Emphysema2
Heart Failure2
Lung Diseases2
Lung Diseases, Obstructive2
Respiratory Insufficiency2
Dyspnea1
Eosinophilia1
Fatigue1
Heart Diseases1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.